TwitterLinkedin

Contact Us

  • Biopharma Excellence
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical
          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Integrated Product Development
            • Market Access
            • Scientific Advice
            • Statistics and Data Sciences
            • Toxicology Services
    • Clinical Development
          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Scientific Advice
            • Statistics and Data Sciences
          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations
          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting
          • Quality

            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
    • Authorization / Approval
          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistics and Data Sciences
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance
          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • ICSR (Individual Safety Case Report) Management
            • Literature Monitoring & Screening
            • Pharmacovigilance Quality & Compliance
            • Signal Management
          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
          • Medical Affairs

            • Healthcare Compliance and Medical Approval
    • Program Management
          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise
          • Industry Expertise

            • Biopharmaceuticals
            • MedTech Services
          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • COVID-19 Support
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Post-Brexit Regulatory Support
            • Statistics and Data Sciences
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Career Opportunities
  • Training
Home > Our Services > Quality Management Systems

Quality Management Systems

The Quality Management System (QMS) is the backbone of every life sciences organization. It is the formalized system that documents procedures, processes and responsibilities for achieving regulatory and quality policies and objectives.

A well designed, tailored and implemented QMS should enable and facilitate your organization to effectively and efficiently progress through R&D, Clinical and Commercial operations. A one-size-fits-all approach is neither practical nor preferable. Instead, the QMS should be phase-appropriate. It should be fitted and adapted to the organization’s development stage – whether you’re in early clinical, late clinical or commercial – and to your business model, for example: in-house manufacture versus virtual or contract manufacture.

The QMS is now more commonly known as the Pharmaceutical Quality System as per ICH Q10. It contains several elements and process that are designed for the assurance of product quality. The design of the PQS is important to ensure that the system is holistic and synergistic as all elements must support and compliment each other to provide a quality backbone for the manufacturing of product. If the PQS is not appropriately planned, implemented and managed, it can become too complex with an ever increasing number of documents and leading to duplication and contradiction.

Want to find out more?

PharmaLex. Confidence beyond compliance.

Contact us for more information

PharmaLex can provide support with PQS planning, development and implementation. We can also remediate PQS that are not working properly and we can also provide support with the implementation or remediation of specific elements of the PQS such as Supplier management, Quality Risk Management, Change Management, Learning Management and deviation management to name a few. We can design and implement PQS for MIA, WDA and MAH.

We have a broad base of expertise through our wide network of consultants, all of whom are SMEs in PQS planning, design and implementation. We can support CSV of computerized systems and have hands on experience with the implementation and comparison of several computerized systems that are used within the PQS. We also have automated tools for QRM. And we can provide case studies of successful PQS support for our clients across several different sectors from small businesses to large multinationals.

QMS Design

Before QMS development starts, it is critically important to understand the organization in which the QMS will be implemented. This will determine how the core requirements will be developed, as well as identifying additional requirements to fit the organization’s specific needs. This structure can broadly be broken into the following components:

We will guide you through the QMS design process, usually in a virtual or in-person workshop. Our consultants will then prepare a QMS Design report that presents you with a QMS framework and work plan for the development of the QMS. Where there is QMS documentation already available our philosophy is to leverage what’s available, update it where needed and develop new documents to fill the gaps.

QMS Development / Update

Whether it’s a resource, expertise or time constraint, PharmaLex is always ready and available to support your QMS development or QMS update. We can provide all development activities in full, including development / update of: the Quality Manual / Site Master File, Standard Operating Procedures (SOPs), Forms, Quality Agreements, Training Material or Work Instructions.

We work in close association with your QA team throughout the development phase and we can flex up or down as your team needs more or less support.

Electronic Quality Management Systems

If your organization is at an inflection point and requires an Electronic QMS your first step should be a conversation with PharmaLex. Whether you are a looking to change a large enterprise systems or implement your first e-QMS in an SME organization we offer expert advice to ensure that your shortlisted options are the best fit for your organization.

We have experience with many systems of all calibers. We have carefully selected and partnered with the leading system providers and have an in-depth understanding of the strengths of each platform. This detailed knowledge means we are ideally placed to support the deployment, configuration, validation and use of these systems in your organization.

Related News

The regulatory and business importance of medical device post-market surveillance
The regulatory and business importance of medical device post-market surveillance
1st July 2022
Medical device software brings new complications around compliance
Medical device software brings new complications around compliance
30th May 2022
Is quality documentation an asset or a burden in regulatory affairs?
Is quality documentation an asset or a burden in regulatory affairs?
6th April 2022

Related Resources

Thought Leadership

  • Why QRM is so important for pharmaceutical organisations
  • ABPI Code feedback
  • The use of LinkedIn and the ABPI Code of Practice
  • Agencies and the ABPI code of practice
  • How does the ABPI Code apply to congresses?
  • Can a robust QMS help you achieve customer satisfaction?
  • Product Launch
  • Quality Investigations & CAPAs "Elementary, my dear Watson"​

Fact Flyers

  • RADIOPHARMA-EXPERTISE @PHARMALEX
  • Medical Device Regulations Transition Support
  • Medical Devices for the Pharmaceutical Industry
  • GxP - Operate a functional and efficient QMS
  • Medical Device Services

Case Studies

  • Business Continuity during Merger
  • Start Up as Wholesale Distributor with business expansion plans
  • Development and Implementation of the Robustness Index
  • Continuous Manufacturing: Development, Optimization and Validation
  • PharmaLex keeps medical device CE marking on track
  • Safety Writing Services
  • Aggregate Report Writing and RMPs
  • Remediation Activities and Operational Support
  • Business Readiness for new German Affiliate
  • End-2-end portfolio maintenance (outsourcing) program
  • Post–M&A PharmaLex program governance
  • Post–M&A pharma infrastructure development

White Papers

  • Transport risk assessment and verification - from theory to practice.
  • Inspection Readiness Audit - Gap Analysis - Mock Inspections
  • When your notified body is losing its designation under the medical device regulation
  • Top tips for a successful EU Orphan Drug Designation application
  • Tips for writing an outstanding Clinical Overview
  • The Medical Literature Monitoring of the EMA
  • Monitoring Compliance with Safety Exchange Agreements
  • Implementation of Eudravigilance Data Analysis System (EVDAS) in signal detection
  • QMS aspects of the Medical Device Regulation
  • The medical device regulations and their implications on device vigilance
  • In Vitro Diagnostic Medical Devices Regulation – Summary of changes and impact for manufacturers
  • Medical Device Software and Mobile Apps
  • Navigating the regulatory submission process for a class III medical device with ancillary medicine
  • The Medical Device Regulation – Readiness for May 2021
  • Software, AI and Medical Devices - What's Up?

Webinars

  • Get Your Design in Control
  • Medical Device Risk Management for Patient and Product Safety
  • Basic rules of pharmaceutical advertising in France
  • QbD – Analytical Quality by Design
  • QbD and Process Characterization
  • An Update to In Vitro Diagnostics Regulatory Requirements Worldwide
  • Medical Device Software: Current Developments in the Regulatory World
  • Medical Device Clinical Evaluation Reports (CERs) -What you need to know
  • The applicability of EU Codes to pharma activities and materials
  • Implementation of an efficient QRM program
  • Vendor Management Programs - Ensuring Success!

Infographics

  • Medical Device Regulations
  • Virtual Auditing for GxP Compliance

Video & Animation

  • Using Technology-enabled Smart Services - what are the benefits?
  • SMARTPHLEX - Technology-enabled Smart Solutions
  • SMARTRISK - What is SMARTRISK

Related Services

  • CMC Services
  • Commercialization Readiness
  • Global Procedure Management
  • GxP Services
  • Health Authority / Agency Interaction
  • Healthcare Compliance and Medical Approval
  • ICSR (Individual Safety Case Report) Management
  • Market Access
  • Marketing and Labeling Activities
  • MedTech Services
  • PAI Readiness
  • SMARTPHLEX
  • SMARTRISK
  • Tech Transfer / Scale-up
  • Toxicology Services
  • Virtual Audits

What our clients say

I just wanted to relay our sincere thanks to you and the team for two really excellent days training. It was well organized and structured to cover regulatory expectations, GMP principle and routine work challenges of industry. The presenters and moderator were highly skilled in this area to accommodate any queries raised during the training session and were well able to keep the team engaged even in remote/virtual training session. The design of training slides was impressive and the use of technology to make virtual training was remarkable.

Lorraine Henry
Compliance Lead, Qualified Person, Amneal Ireland Limited

During the bid defense we felt that you worked well as team and are very dynamic. Preparation of such a complex dossier really needs to be done in such a way.

Large Pharma, Germany
VP Regulatory Affairs
Biopharma Excellence Website Image

PharmaLex Brings You Biopharma Excellence

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.

Visit Website
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
pharmalexglobal PharmaLex @pharmalexglobal ·
5h

Join our webinar to learn more about 👉 Integrated product development for new osteoarthritis treatments on September 20, 4-5 PM CET

Register now: https://go.pharmalex.com/pharmalex-webinar-integrated-product-development-osetoarthritis-treatments?utm_source=SocialMedia&utm_medium=Webinar&utm_campaign=IPD

COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY
  • We really appreciate your responsiveness and availability during our previous exchanges and it is what we are waiting for from our partner.

    Small Medium Sized Company, UK
    Head of Regulatory Affairs
PharmaLex
©2022 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit LogoSGS Logo

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

Many thanks for your understanding.

The PharmaLex Team

    Please DO NOT send us event/conference information.
    We will not respond and these will be deleted immediately.





    Select your state:

    .
    If you do not wish to receive any communication from us, you may unsubscribe at any time.

    #AskTheExpert #TogetherBEYONDCOVID19





      Select your state:

      .
      You can unsubscribe at any time at data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      #TogetherBEYONDCOVID19

      We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for